Although acute myocarditis has not been observed as an adverse event in landmark trials of COVID-19 vaccines, it has been reported as a rare complication in real-world. We identified five cases of acute myocarditis with consistent temporal association to administration of COVID-19 vaccine and described clinical, serological, echocardiographic and cardiac magnetic resonance findings both in the acute phase and after a median follow up of 6 months.
{ACUTE} {MYOCARDITIS} {FOLLOWING} {COVID}-19 {VACCINATION}: A {PECULIAR} {CASE} {SERIES} / Corradetti, S., Sclafani, M., Mistrulli, R., Gallo, G., Pagannone, E., Di Girolamo, M., Autore, C., Volpe, M., Battistoni, A.. - In: JOURNAL OF HYPERTENSION. - ISSN 0263-6352. - 40:Suppl 1(2022). [10.1097/01.hjh.0000837152.13471.cf]
{ACUTE} {MYOCARDITIS} {FOLLOWING} {COVID}-19 {VACCINATION}: A {PECULIAR} {CASE} {SERIES}
Sara CorradettiPrimo
;Matteo SclafaniSecondo
;Raffaella Mistrulli;Erika Pagannone;Camillo Autore;Massimo VolpePenultimo
;Allegra BattistoniUltimo
2022
Abstract
Although acute myocarditis has not been observed as an adverse event in landmark trials of COVID-19 vaccines, it has been reported as a rare complication in real-world. We identified five cases of acute myocarditis with consistent temporal association to administration of COVID-19 vaccine and described clinical, serological, echocardiographic and cardiac magnetic resonance findings both in the acute phase and after a median follow up of 6 months.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
